Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by gamaray

Order by:

C.TCF	RE:RE:RE:RE:RE:RE:RE:RE:Supremely Undervalued Investment Opportunity It seems the data is not transferred to TCF yet. Not sure how there are going... June 14, 2024
C.TCF	TCF and litigation announced in the annual report that there are two cases related to offshore... June 12, 2024
C.TCF	perforations and workovers they promised to start the work mid-june. Is there any update on the perfs... June 12, 2024
C.TCF	RE:RE:RE:RE:Supremely Undervalued Investment Opportunity i heard the same about unpaid invoices. This is sad not exciting. June 12, 2024

Featured News Links

U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material

Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success

Have you held units of a TD mutual fund, other than through a discount broker? Learn more.

BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*

Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences

Featured Company

BioVaxys Technology Corp. C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ... view more »